Santa Clara, located in Silicon Valley, California, became an unlikely focal point for modern longevity research when biotech startup Ambrosia LLC established its headquarters here in 2016. The city, with a population of approximately 127,000, sits in the heart of the tech corridor about 45 miles south of San Francisco. Ambrosia's clinical facilities conducted controversial parabiosis trials, charging participants $8,000 per liter of young blood plasma transfusions. The company's research drew both scientific scrutiny and media attention for its attempts to commercialize anti-aging treatments inspired by studies showing rejuvenating effects when older mice shared blood circulation with younger ones.
Ambrosia LLC founded by Jesse Karmazin, begins FDA-approved clinical trials
Clinical trials conducted injecting young blood plasma into older patients
FDA issues safety warning about young blood plasma treatments
“Santa Clara, California. June 2016. Silicon Valley start-up Ambrosia LLC obtains approval to begin clinical trials on an experimental treatment to reverse aging.”
Unlike traditional archaeological sites, Santa Clara's significance lies in its role as a modern laboratory for age-old human obsessions with longevity and vitality. The Ambrosia LLC trials represented a contemporary attempt to scientifically validate practices that echo throughout human history, from ancient Egyptian mummification techniques to medieval alchemical pursuits of the elixir of life.
Jesse Karmazin, a Stanford-trained physician, founded Ambrosia based on parabiosis research showing that when old and young mice share circulatory systems, the older animals experience cellular rejuvenation. The company's Santa Clara facilities became a controversial testing ground where participants, primarily wealthy individuals seeking anti-aging treatments, paid substantial sums for transfusions of plasma from donors under age 25.
The scientific community remained largely skeptical of Ambrosia's approach, with many researchers arguing that the company was premature in commercializing treatments before establishing clear efficacy through rigorous trials. The FDA's 2019 safety warning effectively ended the company's operations, citing potential risks including allergic reactions, lung injury, and circulatory overload.
What remains genuinely intriguing is the underlying biological mechanism that parabiosis research has revealed in laboratory settings. While Ambrosia's commercial approach faced criticism, legitimate scientific studies continue exploring how factors in young blood might influence aging processes, leaving open questions about the biological basis for humanity's ancient beliefs in the life-giving properties of blood and vital essences.
Participants in Ambrosia's trials paid $8,000 for one liter of young blood plasma or $12,000 for two liters
The company's name 'Ambrosia' directly references the food of the Greek gods believed to confer immortality
Santa Clara is also home to Intel's headquarters, creating an intersection of biological and technological innovation
The FDA warning specifically cautioned against 'young donor plasma' treatments being marketed for conditions including aging, memory loss, and Alzheimer's disease
Santa Clara is easily accessible to visitors as part of the greater Silicon Valley area, though the former Ambrosia facilities are not open for tours. The city offers typical Silicon Valley attractions including the Intel Museum and Levi's Stadium, home to the San Francisco 49ers.
San Jose is approximately 5 miles southeast, while San Francisco is about 45 miles northwest.
Santa Clara enjoys mild Mediterranean climate year-round, making any season suitable for visits. Spring and fall offer the most comfortable temperatures for exploring the broader Silicon Valley region.
Silicon Valley (Way of the Future Church)
Both locations in Silicon Valley represent modern technological approaches to ancient human questions about consciousness and longevity
Cambridge University
University research institutions have long been centers for scientific investigation of life extension and human enhancement technologies
Royal Society, London
Historic scientific institutions have documented centuries of human attempts to understand and extend life through various means